Search

everythinglearnresearchcommunity

for

Search:↓

A woman with Kallman's syndrome also developed alopecia universalis, a condition not previously linked to Kallman's.

Primary care doctors should address female sexual dysfunctions to improve women's sexual health and life quality.

Patients with chronic skin conditions on systemic treatments did not have worse COVID-19 outcomes and could resume their treatments after recovery.

Neoadjuvant chemotherapy followed by surgery leads to fewer severe complications and better quality of life than immediate surgery in advanced ovarian cancer patients with high tumor load.

Hyaluronic acid injections can improve mouth opening and quality of life in scleroderma patients.

Tapinarof cream at 1% concentration is effective and better tolerated for treating atopic dermatitis than the 2% concentration.

The document says menstruation is important for women's health, discusses menstrual disorders, and suggests personalized treatment options.

Higher leptin levels link to hair loss.

The new SLICC criteria for diagnosing lupus are more sensitive and accurate than the old criteria.

Jieduquyuziyin prescription helps treat SLE with atherosclerosis by improving cholesterol removal and reducing inflammation.

Most patients with Systemic Lupus Erythematosus experience fatigue, skin issues, and joint pain.

The document concludes that various childhood hair and nail disorders exist, some may improve on their own, and advances in genetics and immunology could enhance treatment and counseling.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Experts discussed treatments for skin conditions in children, emphasizing hydration, cautious medication use, and early intervention for infections.

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

Hair follicles are important for drug delivery through the skin, but better methods are needed to understand and improve this process.

CCCA is a scarring hair loss condition mainly in African descent women, possibly caused by genetics and hairstyling, treated with gentle hair care and medications.

Different sebaceous gland diseases can be treated with medications, hormone therapy, or surgical methods.

Trichoscopy is a useful method for identifying primary cicatricial alopecias and their specific types.

The conclusion is that genetic testing is important for diagnosing and treating various genetic hair disorders.

Botulinum toxin is effective for various skin conditions, but more research and awareness of side effects are needed.

The document concludes that understanding hair follicle histology and the hair cycle is crucial for diagnosing alopecia.

Skin can produce blood cells, often due to disease, which might lead to new treatments for skin and blood conditions.

Autoimmune diseases like lupus, dermatomyositis, and scleroderma can cause hair loss and other hair problems, and treatments for these diseases might also affect hair.

Different rheumatological diseases can cause specific skin problems.

Ixekizumab successfully treated a rare hair loss condition, leading to complete hair regrowth.

Bacteria in our hair can affect its health and growth, and studying these bacteria could help us understand hair diseases better.

Topical clobetasol is recommended over mycophenolate mofetil for treating Lichen Planopilaris due to better safety and patient satisfaction.

Maternal Nano-Se supplements improve fetal hair follicle development in cashmere goats.